CJC-1295 without DAC (modified GRF 1-29) is a synthetic analog of growth hormone-releasing hormone (GHRH) with modifications that extend its half-life. It acts at the GHRH receptor on pituitary somatotrophs to stimulate growth hormone release. Principal research areas include growth hormone axis signaling, somatotrope regulation, and metabolic research models. Supplied as a lyophilized research material for laboratory research applications.